H Michael Cohen Joins Masimo’s Board of Directors

Masimo, a global medical technology developer and manufacturer of innovative noninvasive patient monitoring technologies, announced today that H Michael Cohen, former Vice Chairman of Healthcare Investment Banking at Deutsche Bank Securities, has been elected to Masimo’s Board of Directors. Cohen has almost 30 years of experience in the healthcare industry. Over the past 19 years, he has held various roles at Deutsche Bank, including Global Head, Healthcare Investment Banking and most recently Vice Chairman, Healthcare Investment Banking. Prior to joining Deutsche Bank, Cohen worked at SG Cowen, Union Bank of Switzerland, and Booz Allen Hamilton. Cohen began his career in healthcare at Hambrecht & Quist, where he was a member of the equity research team covering biotechnology, medical device, and diagnostic companies. He received his B.A. in Economics from the University of Vermont and his M.B.A. from Columbia University.

Joe Kiani, Founder, Chairman and CEO of Masimo, said, “We’re thrilled to welcome Michael to our Board of Directors. With his vast experience in healthcare investment banking and deep understanding of the medical technology industry and the complexities of global healthcare, he’ll be an excellent addition. We look forward to benefiting from his expertise and insight as Masimo continues to grow.” “I’m honored to join Masimo’s Board,” said Cohen. “It’s been a privilege to observe Masimo grow from its humble beginning in 1989 into the global leader in noninvasive monitoring it has become today, and I’m excited to help shape the next stage of its journey while driving long-term value for Masimo and its shareholders.” – Medical Buyer Bureau